INBS Stock Summary and Trading Ideas (Intelligent Bio Solutions | NASDAQ:INBS)

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Intelligent Bio Solutions trades on the NASDAQ stock market under the symbol INBS.

As of January 21, 2026, INBS stock price declined to $9.87 with 404,059 million shares trading.

INBS has a beta of 1.05, meaning it tends to be more sensitive to market movements. INBS has a correlation of 0.02 to the broad based SPY ETF.

INBS has a market cap of $12.00 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, INBS traded as high as $3,840.02 and as low as $4.03.

The top ETF exchange traded funds that INBS belongs to (by Net Assets): VXF.

INBS has underperformed the market in the last year with a price return of -29.0% while the SPY ETF gained +15.9%. INBS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -8.6% and -7.8%, respectively, while the SPY returned +2.4% and -0.9%, respectively.

INBS support price is $12.10 and resistance is $15.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INBS shares will trade within this expected range on the day.